SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-002063
Filing Date
2021-01-05
Accepted
2021-01-05 17:21:55
Documents
3
Period of Report
2021-01-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d30931d8k.htm 8-K 20229
2 EX-10.1 d30931dex101.htm EX-10.1 60077
3 EX-99.1 d30931dex991.htm EX-99.1 12260
  Complete submission text file 0001193125-21-002063.txt   93829
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39425 | Film No.: 21507180
SIC: 2836 Biological Products, (No Diagnostic Substances)